Cargando…

Acute respiratory distress syndrome; A rare complication caused by usage of ruxolitinib

Ruxolitinib-associated acute respiratory distress has rarely been reported, mostly due to discontinuation of treatment. Herein we report a 58-year-old male patient with primary myelofibrosis who presented with malaise and dyspnea 15 days after initiation of the treatment. The patient was diagnosed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerget, Bugra, Araz, Omer, Ucar, Elif Yilmazel, Akgun, Metin, Sağlam, Leyla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608559/
https://www.ncbi.nlm.nih.gov/pubmed/28970999
http://dx.doi.org/10.1016/j.rmcr.2017.09.003